• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lyka Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 677.0
  • ISIN : INE933A01014
110.16 0 (-0.40%)
  • As on 12 Jul 2025 (EOD)

  • Today’s Low

    108.99

  • Today’s High

    112.39

  • Open

    109.20

  • Perv Close

    110.60

  • 52W Low

    96.80

  • 52W High

    176.59

Key Indicators

  • P/E(TTM)

    47.86

  • Mar.Cap (₹Cr.)

    393.16

  • Div & Yield %

    0.00

  • Book Value(₹)

    37.81

  • Debt-Equity Ratio

    -0.40

  • AGM Date

    11-Jul-2025

  • EPS

    2.31

  • P/E Ratio

    47.86

Financials Ratios

  • Debt-Equity Ratio

    1.14

  • Mar.Cap (₹Cr.)

    393.16

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.69

  • BV (₹)

    37.80

  • Sales( ₹ in Cr.)

    134.70

  • NP (in Cr.)

    8.23

  • NP Var(%)

    456.0

  • Div%

    0.0

  • CPS (₹)

    4.10

  • EPS (₹)

    2.30

  • Traded Value (₹ in Lakhs)

    394.55

  • 52 Week High

    176.59

  • 52 Week Low

    96.80

  • Price BSE

    111.0

  • Price NSE

    110.00

  • Market Capital( in Cr.)

    394.55

  • P/C Ratio

    27.00

  • P/E Ratio

    48.20

  • Price Vs.BV

    2.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 134.70 106.40 80.59 164.35 62.26 40.74
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 134.70 106.40 80.59 164.35 62.26 40.74
Other Income 2.34 1.65 3.45 2.72 2.21 4.34
Stock Adjustments 1.37 0.79 1.21 0.40 -2.04 0.28
Total Income 138.41 108.84 85.25 167.47 62.43 45.36
EXPENDITURE :            
Raw Materials 54.60 43.73 30.27 31.27 21.48 21.30
Power and Fuel Cost 3.90 3.92 3.57 3.88 2.91 2.52
Employee Cost 34.09 26.01 17.48 16.22 13.03 11.71
Other Manufacturing Expenses 5.22 4.49 2.81 2.25 2.27 1.40
Selling and Administration Expenses 18.99 13.20 11.18 12.04 5.63 5.43
Miscellaneous Expenses 1.39 1.33 8.06 6.26 1.91 31.38
Employee Benefit Expenses 34.09 26.01 17.48 16.22 13.03 11.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 118.19 92.68 73.37 71.93 47.22 73.74
Operating Profit 20.23 16.15 11.88 95.55 15.20 -28.37
Interest 2.30 4.80 11.57 19.92 25.55 19.01
Gross Profit 17.93 11.35 0.31 75.63 -10.35 -47.38
Depreciation 6.45 12.29 13.52 15.39 8.05 7.77
Profit Before Tax 11.48 -0.94 -13.21 60.24 -18.40 -55.15
Current Tax 2.72 1.60 0.21 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.52 -0.26 -0.13 20.34 -3.94 0.24
Reported Net Profit 8.23 -2.27 -13.29 39.90 -14.46 -55.39
Extraordinary Items 0.00 0.04 -7.06 -3.09 -1.43 -27.63
Adjusted Net Profit 8.23 -2.31 -6.23 42.99 -13.03 -27.76
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -103.65 -101.38 -88.09 -127.99 -113.54 -58.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -95.42 -103.65 -101.38 -88.09 -127.99 -113.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.31 -0.69 -4.33 13.91 -5.04 -19.31
Earnings Per Share(Adj)-Unit Curr 2.31 -0.69 -4.33 13.91 -5.04 -19.31
Book Value 37.81 27.28 19.22 15.49 1.54 6.55
Book Value(Adj)-Unit Curr 37.81 27.28 19.22 15.49 1.54 6.55

Shareholding Pattern

  • Promoter Group

    58.16%

  • Public Share Holding

    41.84%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,645,631 43.84 15,645,631 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,112,586 14.33 5,112,586 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,758,217 58.16 20,758,217 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.00 50 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 55,385 0.16 55,385 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 500 0.00 0 2
Insurance Companies 101,000 0.28 100,000 2
Mutual Funds / UTI 3,400 0.01 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 132,651 0.37 132,651 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 293,636 0.82 288,086 16
2] Non Institution
Bodies Corporate 1,872,389 5.25 1,871,527 171
Clearing Members 1,295 0.00 1,295 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 500 0.00 500 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 398,474 1.12 393,517 251
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 846,351 2.37 846,243 591
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,394,132 9.51 3,394,132 59
Individuals holding nominal share capital up to Rs. 1 lakh 7,815,763 21.90 7,617,753 27,069
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 14,638,147 41.01 14,434,210 28,159
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,690,000 100.00 35,480,513 28,189

Company Background

Lyka Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lyka Labs Ltd
  • BSE Code : 677.0
  • ISIN : INE933A01014

  • Incorporation Year

    1976

  • Registered Office

    4801/B & 4802/A
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-02646-221422/220549

  • FAX

    91-02646-250692

  • Chairman

    Babulal Jain

  • Managing Director

    KUNAL NARENDRA GANDHI

  • Company Secretary

    Shekhar R Singh

  • Auditor

    D Kothary & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Lyka Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lyka Labs 110.55 137.04 134.70 47.86 6.37
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10